Company / Cost of Revenue
SI-BONE, Inc. Cost of Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$41.0M
FY2025
5-year range
$10.4M / $41.0M
FY2021-FY2025
Trend
+17.1%
vs FY2024
Sector context
#100 of 107
Health Care
What the data says
Among 107 Health Care companies, SI-BONE, Inc. is in the top 7% for cost of revenue. Cost of Revenue has increased for 7 consecutive years, from $5M in FY2018 to $41M in FY2025.
Based on SEC 10-K filings.
$41M in FY2025 with a 5-year CAGR of +35.8%.
Increased from $29M to $41M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +37.7%
- 5-Year CAGR
- +35.8%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 107This company $41.0M Sector average $11.8B
▼
-99.7% below sector average
Key checks
Key Insights
- SI-BONE, Inc.'s cost of revenue has grown for 7 consecutive years.
- 5-year CAGR of +35.8%, indicating consistent growth.
- In FY2025, cost of revenue increased 17.1% year-over-year.
- Ranks #100 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- Negative profit margin: -18.5%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $41.0M | +17.1% |
| FY2024 | $35.1M | +19.0% |
| FY2023 | $29.5M | +87.6% |
| FY2022 | $15.7M | +50.6% |
| FY2021 | $10.4M | +17.1% |
| FY2020 | $8.9M | +31.1% |
| FY2019 | $6.8M | +40.5% |
| FY2018 | $4.8M | -5.5% |
| FY2017 | $5.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026